COX-2-Mediated Regulation of VEGF-C in Association With Lymphangiogenesis and Lymph Node Metastasis in Lung Cancer

Anatomical Record

Volumn 293, Issue 11, 2010, Pages 1838-1846

  Liu, Huidong ^a   Yang, Yanmei ^a   Xiao, Jianbing ^a   Lv, Yanhong ^a   Liu, Yan ^a   Yang, Huike ^a   Zhao, Linghui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

COX 2; Human lung cancer; VEGF C

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; CELECOXIB; CYCLOOXYGENASE 2; PROSTAGLANDIN E RECEPTOR; SMALL INTERFERING RNA; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; HUMANS; LUNG NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; PYRAZOLES; RNA, SMALL INTERFERING; SULFONAMIDES; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

ANIMALIA;

EID: 78049515203     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21240     Document Type: Article

References (39)

1. Alitalo K, Carmeliet P. 2002. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 3: 219-227.
2. Alitalo K, Mohla S, Ruoslahti S. 2004. Lymphangiogenesis and cancer meeting report. Cancer Res 64: 9225-9229.
3. Banerji S, Ni J, Wang SX. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801.
4. Bono P, Wasenius VM, Heikkila P. 2004. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 10: 7144-7149.
5. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. 2001. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-690.
6. Bronckaers A, Gago F, Balzarini J, Liekens S. 2009. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev 29: 903-953.
7. Costa C, Soares R, Reis-Filho JS, Leitão D, Amendoeira I, Schmitt FC. 2002. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55: 429-434.
8. Eisinger AL, Prescott SM, Jones DA, Stafforini DM. 2007. The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins Other Lipid Mediat 82: 147-154.
9. Ferrara N. 1999. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56: 794-814.
10. Fujita T, Matsui M, Takaku K. 1998. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res 58: 4823-4826.
11. Gately S. 2000. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19: 19-27.
12. Gu P, Su Y, Guo S. 2008. Over-expression of COX-2 induces human ovarian cancer cells (CAOV-3) viability, migration and proliferation in association with PI3-k/Akt activation. Cancer Invest 26: 822-829.
13. Hida T, Yatabe Y, Achiwa H. 1998. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58: 3761-3764.
14. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. 2004. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580.
15. Joukov V, Pajusola K, Kaipainen A. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298.
16. Kozaki K, Koshikawa K, Tatematsu Y. 2001. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene 20: 4228-4234.
17. Liu H, Yang Y, Xiao J, Lv Y, Liu Y, Yang H, Zhao L. 2009. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C. Anat Rec 292: 1577-1583.
18. Liu X, Kirschenbaum A, Yao S. 2000. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 164: 820-825.
19. Liu Z, Wang X, Lu Y, Han S, Zhang F, Zhai H, Lei T, Liang J, Wang J, Wu K, Fan D. 2008. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. Carcinogenesis 29: 1219-1227.
20. Majima M, Hayashi I, Muramatsu M. 2000. Cyclooxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 30:641-649.
21. Mansour EG, Ravdin PM, Dressler L. 1994. Prognostic factors in early breast carcinoma. Cancer 74(1 Suppl): 381-400.
22. Mattila MM, Ruohola JK, Karpanen T. 2002. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98: 946-951.
23. Murata H, Kawano S, Tsuji S. 1999. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol l94: 451-455.
24. Oliver G, Detmar M. 2000. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16: 773-783.
25. Rozic JG, Chakraborty C, Lala PK. 2001. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 93: 497-506.
26. Seno H, Oshima M, Ishikawa T. 2002. Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in APC716 mouse intestinal polyps. Cancer Res 62: 506-511.
27. Siironen P, Ristimäki A, Narko K, Nordling S, Louhimo J, Andersson S, Haapiainen R, Haglund C. 2006. VEGF-C and COX-2 expression in papillary thyroid cancer. Endocrine Relat Cancer 13: 465-473.
28. Skobe M, Hawighorst T, Jackson DG. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198.
29. Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. 2004. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 15: 64: 554-564.
30. Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, Hung MC, Kuo ML. 2006. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9: 209-223.
31. Swami S, Krishnan AV, Moreno J, Bhattacharyya RB, Peehl DM, Feldman D. 2007. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer. J Nutr 137: 205S-210S.
32. Taketo MM. 1998. Cyclooxygenase-2 inhibitors in tumorigenesis. J Natl Cancer Inst 90: 1529-1536.
33. Timoshenko AV, Chakraborty C, Wagner GF, Lala PK. 2006. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer 94: 1154-1163.
34. Tsujii M, Kawano S, Tsuji S. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716.
35. Vallböhmer D, Peters JH, Kuramochi H, Oh D, Yang D, Shimizu D, DeMeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, Danenberg PV, DeMeester TR. 2006. Molecular determinants in targeted therapy for esophageal adenocarcinoma. Arch Surg 141: 476-481.
36. Villegas I, Sánchez-Fidalgo S, Alarcón de la Lastra C. 2008. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res 52: 1040-1061.
37. Wang WR, Pan ZC, Yan XC. 1987. Isolation of a metastatic ascitic subpopulation from a human lung adenocarcinoma cell line in nude mice and studies on its biological properties. Chinese J Oncol 9: 412-414.
38. Yamamoto Y, Shiraishi I, Dai P, Hamaoka K, Takamatsu T. 2007. Regulation of embryonic lung vascular development by vascular endothelial growth factor receptors, Flk-1 and Flt-1. Anat Rec 290: 958-973.
39. Yang HJ, Li Y, Chen YZ, Lu BJ, Chen F, Chen Y, Li P, Fu SB. 2003. Sequence analysis and expression study of BRI gene in two lung adenocarcinoma cell lines with different metastatic potential. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20: 292-296.